A detailed history of Hoyle Cohen, LLC transactions in Amgen Inc stock. As of the latest transaction made, Hoyle Cohen, LLC holds 5,404 shares of AMGN stock, worth $1.68 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,404
Previous 4,709 14.76%
Holding current value
$1.68 Million
Previous $1.36 Million 13.27%
% of portfolio
0.12%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $186,864 - $225,569
695 Added 14.76%
5,404 $1.54 Million
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $311,442 - $351,344
1,218 Added 34.89%
4,709 $1.36 Million
Q3 2023

Nov 02, 2023

BUY
$218.65 - $271.46 $13,774 - $17,101
63 Added 1.84%
3,491 $938,000
Q2 2023

Aug 07, 2023

SELL
$214.27 - $253.37 $10,713 - $12,668
-50 Reduced 1.44%
3,428 $761,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $23,590 - $29,974
103 Added 3.05%
3,478 $913,000
Q3 2022

Nov 02, 2022

SELL
$224.46 - $253.15 $224 - $253
-1 Reduced 0.03%
3,375 $761,000
Q2 2022

Jul 27, 2022

SELL
$230.71 - $256.74 $57,677 - $64,185
-250 Reduced 6.89%
3,376 $821,000
Q1 2022

May 03, 2022

BUY
$219.27 - $242.57 $124,983 - $138,264
570 Added 18.65%
3,626 $877,000
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $14,319 - $16,387
72 Added 2.41%
3,056 $688,000
Q2 2021

Aug 12, 2021

SELL
$233.58 - $259.14 $3,503 - $3,887
-15 Reduced 0.5%
2,984 $727,000
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $4,216 - $4,913
-19 Reduced 0.63%
2,999 $746,000
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $116,845 - $139,141
540 Added 21.79%
3,018 $694,000
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $23,465 - $26,095
-100 Reduced 3.88%
2,478 $630,000
Q2 2020

Jul 29, 2020

SELL
$197.81 - $242.74 $98,905 - $121,370
-500 Reduced 16.24%
2,578 $608,000
Q1 2020

May 08, 2020

SELL
$182.24 - $241.7 $13,668 - $18,127
-75 Reduced 2.38%
3,078 $624,000
Q2 2019

Aug 09, 2019

BUY
$166.7 - $195.41 $91,685 - $107,475
550 Added 21.13%
3,153 $581,000
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $36,174 - $40,776
-200 Reduced 7.14%
2,603 $495,000
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $3,705 - $4,177
20 Added 0.72%
2,803 $581,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $16,943 - $19,800
-100 Reduced 3.47%
2,783 $474,000
Q4 2017

Feb 15, 2018

BUY
$168.79 - $188.59 $486,621 - $543,704
2,883
2,883 $501,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hoyle Cohen, LLC Portfolio

Follow Hoyle Cohen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoyle Cohen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hoyle Cohen, LLC with notifications on news.